Following promising trial findings , retatrutide, a novel peptide option for managing non-insulin dependent diabetes , has received regulatory approval from Great Britain's Drug and Regulatory Agency (MHRA https://joycecfvi071882.uzblog.net/retatrutide-compound-peptide-uk-authorization-and-availability-54596105